A comprehensive view of Obesity. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

UK's 10 largest food and drink firms sold 262 products featuring child-appealing packaging, with 78% classed as unhealthy, according to campaign body Bite Back; group calls on government to restrict unethical marketing to halt rise in childhood obesity
Published: May 03, 2024 by Daily Mail
Amgen halts development of weight loss pill, shifts focus to its injectable drug MariTide and other obesity products; prepares for stage two trial of MariTide as diabetes treatment
Published: May 03, 2024 by Baystreet US News Alerts
Novo Nordisk raises 2024 outlook despite struggles with Wegovy weight-loss drug production, cuts Wegovy prices due to competition from Lilly's Zepbound; price cuts predicted to continue due to increased volume and competition in the obesity drug market
Published: May 03, 2024 by CE Noticias Financieras (Latin America)
Novo Nordisk's Q1 earnings beat expectations, with a 22% YoY increase in net sales to US$9.4B and a 28% YoY rise in net profit to US$3.65B; results driven by a surge in demand for its weight loss and diabetes drugs Ozempic and Wegovy
Published: May 02, 2024 by Forbes
CO SB054: Diabetes Prevention & Obesity Treatment Act
Published: May 02, 2024 by Colorado 2024 Regular Session

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count